202 related articles for article (PubMed ID: 30897259)
1. Microneedle Array-Based Platforms for Future Theranostic Applications.
Howells O; Rajendran N; Mcintyre S; Amini-Asl S; Henri P; Liu Y; Guy O; Cass AEG; Morris MC; Sharma S
Chembiochem; 2019 Sep; 20(17):2198-2202. PubMed ID: 30897259
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress in Microneedles-Mediated Diagnosis, Therapy, and Theranostic Systems.
Yang J; Yang J; Gong X; Zheng Y; Yi S; Cheng Y; Li Y; Liu B; Xie X; Yi C; Jiang L
Adv Healthc Mater; 2022 May; 11(10):e2102547. PubMed ID: 35034429
[TBL] [Abstract][Full Text] [Related]
3. Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond.
Mitragotri S; Lammers T; Bae YH; Schwendeman S; De Smedt S; Leroux JC; Peer D; Kwon IC; Harashima H; Kikuchi A; Oh YK; Torchilin V; Hennink W; Hanes J; Park K
J Control Release; 2017 Jan; 246():183-184. PubMed ID: 28110715
[No Abstract] [Full Text] [Related]
4. The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms.
Korolev D; Postnov V; Aleksandrov I; Murin I
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680176
[TBL] [Abstract][Full Text] [Related]
5. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
Opoku-Damoah Y; Wang R; Zhou J; Ding Y
Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
Duarah S; Sharma M; Wen J
Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
8. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
9. A simple method of microneedle array fabrication for transdermal drug delivery.
Kochhar JS; Goh WJ; Chan SY; Kang L
Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
[TBL] [Abstract][Full Text] [Related]
10. 3D printing applications for transdermal drug delivery.
Economidou SN; Lamprou DA; Douroumis D
Int J Pharm; 2018 Jun; 544(2):415-424. PubMed ID: 29355656
[TBL] [Abstract][Full Text] [Related]
11. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
12. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
13. Graphene Quantum Dots for Theranostics and Bioimaging.
Schroeder KL; Goreham RV; Nann T
Pharm Res; 2016 Oct; 33(10):2337-57. PubMed ID: 27207272
[TBL] [Abstract][Full Text] [Related]
14. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
Al-Qallaf B; Das DB
J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo evaluation of a microneedle array device for transdermal application.
Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
[TBL] [Abstract][Full Text] [Related]
16. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
17. Challenges of moving theranostic nanomedicine into the clinic.
Singh D; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2020 Jan; 15(2):111-114. PubMed ID: 31903854
[No Abstract] [Full Text] [Related]
18. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
19. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy.
Medina-Reyes EI; Garcia-Viacobo D; Carrero-Martinez FA; Chirino YI
Crit Rev Ther Drug Carrier Syst; 2017; 34(1):35-61. PubMed ID: 28322140
[TBL] [Abstract][Full Text] [Related]
20. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
Cahill EM; O'Cearbhaill ED
Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
